Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Niklas Schäfer, Martin Glas & Ulrich Herrlinger. (2012) Primary CNS lymphoma: a clinician’s guide. Expert Review of Neurotherapeutics 12:10, pages 1197-1206.
Read now
Read now
Articles from other publishers (15)
Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri, Julia Furtner, Jaime Gallego Perez-Larraya, Roger Henriksson, Andreas F Hottinger, Benjamin Kasenda, Florence Lefranc, Alexander Lossos, Catherine McBain, Matthias Preusser, Patrick Roth, Roberta Rudà, Uwe Schlegel, Riccardo Soffietti, Carole Soussain, Martin J B Taphoorn, Valérie Touitou, Michael Weller & Jacoline E C Bromberg. (2023) European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL). Neuro-Oncology 25:1, pages 37-53.
Crossref
Crossref
Xiangwei Luo, Youzhi Zhu, Yu Zhang, Qian Zhang, Xiao Wang & Xuefei Deng. (2022) Parameters of MR perfusion-weighted imaging predict the response and prognosis to high-dose methotrexate-based chemotherapy in immunocompetent patients with primary central nervous system lymphoma. Journal of Clinical Neuroscience 95, pages 151-158.
Crossref
Crossref
Stav Gazal, Eyal Lebel, Yosef Kalish, Chen Makranz, Moshe E. Gatt, Neta Goldschmidt & Boaz Nachmias. (2021) Venous Thromboembolism Prophylaxis with Low-Molecular-Weight Heparin in Primary Central Nervous System Lymphoma. Oncology Research and Treatment 44:1-2, pages 52-57.
Crossref
Crossref
Timur Koca, Aylin Fidan Korcum, Yasemin Şengün, Melek Gamze Aksu & Mine Genç. (2020) Evaluation of The Effectiveness and Side Effects of Radiotherapy in Patients With Primary Nervous System Lymphoma. A Single Center Experience. Integrative Journal of Medical Sciences.
Crossref
Crossref
Caroline Houillier, Luc Taillandier, Sylvain Dureau, Thierry Lamy, Mouna Laadhari, Olivier Chinot, Cecile Moluçon-Chabrot, Pierre Soubeyran, Remy Gressin, Sylvain Choquet, Gandhi Damaj, Antoine Thyss, Julie Abraham, Vincent Delwail, Emmanuel Gyan, Laurence Sanhes, Jérôme Cornillon, Reda Garidi, Alain Delmer, Marie-Laure Tanguy, Ahmad Al Jijakli, Pierre Morel, Pascal Bourquard, Marie-Pierre Moles, Adrien Chauchet, Thomas Gastinne, Jean-Marc Constans, Adriana Langer, Antoine Martin, Patricia Moisson, Lucette Lacomblez, Nadine Martin-Duverneuil, Daniel Delgadillo, Isabelle Turbiez, Loïc Feuvret, Nathalie Cassoux, Valérie Touitou, Damien Ricard, Khê Hoang-Xuan & Carole Soussain. (2019) Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study. Journal of Clinical Oncology 37:10, pages 823-833.
Crossref
Crossref
Lu Xie, Wei Guo, Yi Yang, Tao Ji & Jie Xu. (2017) More severe toxicity of genetic polymorphisms on MTHFR activity in osteosarcoma patients treated with high-dose methotrexate. Oncotarget 9:14, pages 11465-11476.
Crossref
Crossref
Ali Nael, Vighnesh Walavalkar, William Wu, Kambiz Nael, Ronald Kim, Sherif Rezk & Xiaohui Zhao. (2016) CD4-Positive T-Cell Primary Central Nervous System Lymphoma in an HIV Positive Patient. American Journal of Clinical Pathology 145:2, pages 258-265.
Crossref
Crossref
A. Prica, K. Chan & M. Cheung. (2014) Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a cost-effectiveness analysis. Neuro-Oncology 16:10, pages 1384-1391.
Crossref
Crossref
Yuta Shibamoto, Minako Sumi, Shunsuke Onodera, Haruo Matsushita, Chikao Sugie, Yukihisa Tamaki, Hiroshi Onishi, Eisuke Abe, Masahiko Koizumi, Daisuke Miyawaki, Seiji Kubota, Etsuyo Ogo, Takuma Nomiya, Mitsuhiro Takemoto, Hideyuki Harada, Ippei Takahashi, Yoshio Ohmori, Naoya Ishibashi, Sunao Tokumaru & Kazunori Suzuki. (2013) Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005–2009 and a comparison with those treated in 1985–2004. International Journal of Clinical Oncology 19:5, pages 963-971.
Crossref
Crossref
Yasuo Iwadate, Akiko Suganami, Shiro Ikegami, Natsuki Shinozaki, Tomoo Matsutani, Yutaka Tamura, Naokatsu Saeki & Ryuya Yamanaka. (2014) Non-deep-seated primary CNS lymphoma: therapeutic responses and a molecular signature. Journal of Neuro-Oncology 117:2, pages 261-268.
Crossref
Crossref
Hiroshi AOKI, Ryosuke OGURA, Yoshihiro TSUKAMOTO, Masayasu OKADA, Manabu NATSUMEDA, Mizuho ISOGAWA, Seiichi YOSHIDA & Yukihiko FUJII. (2013) Advantages of Dose-dense Methotrexate Protocol for Primary Central Nervous System Lymphoma: Comparison of Two Different Protocols at a Single Institution. Neurologia medico-chirurgica 53:11, pages 797-804.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Oncology 24:6, pages 756-768.
Crossref
Crossref
Anca Prica, Kelvin Chan & Matthew C. Cheung. (2012)
Combined modality therapy
versus
chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a decision analysis
. British Journal of Haematology 158:5, pages 600-607.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Oncology 24:5, pages 587-595.
Crossref
Crossref
Prathima ProdduturiPhilip J Bierman. (2012) Current and Emerging Pharmacotherapies for Primary CNS Lymphoma. Clinical Medicine Insights: Oncology 6, pages CMO.S7752.
Crossref
Crossref